SCHEMBL21149233

SCHEMBL21149233

c1ccc(-c2ccc(-c3nc(-c4ccc5sc6ccccc6c5c4)nc(-c4cccc5sc6ccccc6c45)n3)cc2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM3 Q86V86 1/20 0.39
ALOX5 P09917 1/20 0.36
GPR3 P46089 1/20 0.36
CYP1A2 P05177 1/20 0.36
ADORA2A P29274 2/20 0.35
ADORA1 P30542 2/20 0.35
LIMK1 P53667 2/20 0.34
ALDH1A1 P00352 4/20 0.34
MAPT P10636 4/20 0.34
HPGD P15428 4/20 0.34
MEN1 O00255 3/20 0.34
KMT2A Q03164 3/20 0.34
TSHR P16473 2/20 0.34
ADORA3 P0DMS8 1/20 0.34
ALOX15 P16050 1/20 0.34
ADORA2B P29275 1/20 0.34
F9 P00740 1/20 0.34
KDM4E B2RXH2 2/20 0.33
ATM Q13315 2/20 0.33
SMN1; SMN2 Q16637 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25730550 0.99 ALOX5 (0.37) PIM3ALOX5GPR3CYP1A2ADORA2A
SCHEMBL26080438 0.97 PIM3 (0.40) PIM3ALOX5GPR3CYP1A2ADORA2A
SCHEMBL25950494 0.96 PIM3 (0.41) PIM3ALOX5GPR3CYP1A2LIMK1
SCHEMBL25944421 0.96 PIM3 (0.41) PIM3ALOX5GPR3CYP1A2LIMK1
SCHEMBL19501982 0.96 ALOX5 (0.37) PIM3ALOX5GPR3CYP1A2ADORA2A
SCHEMBL22329592 0.96 ALOX5 (0.37) PIM3ALOX5GPR3CYP1A2ADORA2A
SCHEMBL22700236 0.95 ALDH1A1 (0.36) PIM3ALOX5GPR3CYP1A2ADORA2A
SCHEMBL22329555 0.95 ALDH1A1 (0.36) PIM3ALOX5GPR3CYP1A2ADORA2A
SCHEMBL21149142 0.95 PIM3 (0.38) PIM3ALOX5GPR3CYP1A2ADORA2A
SCHEMBL22700237 0.95 ALDH1A1 (0.36) PIM3ALOX5GPR3CYP1A2ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230329097-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO LTD (KR) 2023-10-12 US disclosed
US-20230329097-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO LTD (KR) 2023-10-12 US disclosed
US-20190214573-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2019-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190214573-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE OR10J3, OCIAD2, OCIAD1 PIM3 3857/4885ALOX5 306/4885GPR3 1439/4885
US-20230329097-A1 COMPOSITION FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC OPTOELECTRONIC DEVICE, AND DISPLAY DEVICE OR10J3, OCIAD2, OCIAD1 PIM3 3857/4885ALOX5 306/4885GPR3 1439/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.